Autologous CAR-T Cell Manufacturing: Current Standing and Future Directions
A Look at What Drug Manufacturers are Likely Using to Make CAR-T Products
Supplement: MilliporeSigma Sees Opportunity in Continuous Processing
From the GEN Sounds of Science Podcast
Why CAR-T Therapies Don’t Work for Everyone Yet
Selecting the Best Type of T Cells for CAR-T May be Key to the Overall Efficacy of the Therapies
Cell-Centered: Scientists Embrace Cell-Replacement Therapy for Type 1 Diabetes
Forming Beta Cells from Stem Cells
For full access to this article login to GEN Select now.
Laboratory Asset Management Is Thriving
Adherents Say These Services Reduce Costs, Decrease Response Times, and Increase Uptime
- Are lab asset management services worth their salt? Millennium Pharmaceuticals (www.mlnm.com) thinks so. A two-year relationship with Thermo Fisher Scientific (www.thermo.com) has trimmed its annual multimillion-dollar maintenance budget by 15–20% compared to what it would have paid the original equipment manufacturer (OEM), according to Jack Parker, associate director of ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.